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ORIGINAL ARTICLE 
Anterior resection syndrome: Contributing factors and 
its impact on quality of life  
Svetlana Doris Brincat, Josef Lauri, Charles Cini
BACKGROUND   
In Europe, colorectal cancer is the second most common cancer in 
women and third most common in men. Around half of all colorectal 
cancer cases affect the rectum. Surgery is the main curative therapy 
for rectal cancer however this is associated with bowel functional 
disturbances post anterior resection. The wide spectrum of 
symptoms following resection and restitution of rectum is what 
constitutes anterior resection syndrome. The aims of the study were 
to evaluate the incidence of anterior resection syndrome, identify 
correlation with clinical variables and its impact on quality of life.  
METHODS   
Adult patients who had undergone anterior resection between 
January 2014 and December 2016 were recruited. Variable factors 
for low anterior resection syndrome (LARS) were collected 
retrospectively from clinical records. Data was collected using 
validated questionnaires, namely LARS scale and EORTC QLQ-C30. 
Statistical analysis included ordinal logistic regression, one-way 
ANOVA and Scheffe post-hoc test.  
RESULTS   
Between January 2014 and December 2016, 179 patients underwent 
undergone anterior resection, with 55 patients fulfilling the inclusion 
criteria. Symptoms of LARS were identified in 51% of patients (n=27); 
with 23% (n=13) classified as minor and 28% (n=15) as major. Ordinal 
logistic regression showed that distance from anal verge (p=0.02), 
preoperative radiotherapy (p=0.01) and presence of stoma (p=0.02) 
were significantly associated with LARS. Patients with major LARS 
experienced a significant decrease in their quality of life.  
DISCUSSION   
Following anterior resection, patients may suffer from LARS 
adversely impacting their quality of life. Identification of factors 
contributing to LARS and its impact on the quality of life allows for 
better patients stratification in treatment groups and provision of 
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INTRODUCTION 
In Europe, colorectal cancer is the second most 
common cancer in women after breast cancer 
and third most common cancer in men 
following lung and prostate cancer. It accounts 
to 9.7% of all cancers worldwide with 1.8 
million new cases diagnosed annually.  Around 
half of all colorectal cancer cases affect the 
rectum.1 Surgery is the main curative therapy 
for rectal cancer. This involves either an 
abdominal perineal resection (AP) or a 
sphincter-sparing resection. Improvements in 
pre-operative staging and surgical techniques 
have led to the advent of low and ultra-low 
anterior resection, both being sphincter 
sparing surgeries for patients who might have 
otherwise undergone an AP resection. Hence 
for patients in whom a negative distal margin 
can be achieved, low anterior resection is 
preferred as it maintains bowel continence and 
avoids a permanent colostomy. However, 
bowel functional disturbances constitute a 
major problem for many surviving rectal cancer 
patients following anterior resection. The wide 
spectrum of symptoms following resection 
and restitution of rectum is what constitutes 
low anterior resection syndrome (LARS).2  
Studies have shown  that anterior resection 
syndrome may be attributed to sphincter 
injury, denervation during pelvic dissection 
associated with altered rectal sensation, low 
coloanal anastomosis as well as reduced 
capacity and compliance of rectal remnant.3  
Anterior resection syndrome constitutes fecal 
incontinence or urgency, frequent or 
fragmented bowel movements, emptying 
difficulties and increased intestinal gas. 
Although most of the functional impairments 
are clinically recovered following one year 
after surgery, long term studies report the 
presence of bowel dysfunction for years 
following resection.  This dysfunction varies in 
its symptoms and severity and may have 
significant impact on patient’s quality of life.4-5 
Hence, the aims of the study were to evaluate 
the incidence of anterior resection syndrome, 
identify correlation between anterior 
resection syndrome and clinical variables and  
evaluate the impact of anterior resection 
syndrome on quality of life. 
MATERIALS AND METHODS 
All adult patients, under the care of all surgical 
firms at the national acute hospital in Malta, 
who had undergone anterior resection for 
rectal cancer between January 2014 and 
December 2016 were included. Approval from 
data protection unit at Mater Dei hospital was 
sought to obtain access to patient’s details and 
files for data collection. Approval from local 
research ethics committee and the patients’ 
caring consultants was obtained. The study 
was also registered with ClinicalTrials.gov. 
Patients were recruited from data recorded in 
operation record sheets. Patients were 
excluded if they met the below criteria: 
 colon cancer >15cm from anal verge 
 permanent stoma 
 known disseminated or recurrent disease 
 patient without restitution of bowel 
continuity after one year 
All patients were sent a letter by ordinary mail 
which contained an information sheet and a 
consent form describing the study aim and 
declaration of its confidentiality. It also 
contained 2 validated questionnaires: LARS 
scale questionnaire and  EORTC QLQ-30.6-7  
The LARS score is a validated five-score 
questionnaire focusing on bowel symptoms. 
According to the score patients are grouped 
into non-LARS (if score obtained is 0-20 
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points), minor LARS (21-29 points) and major 
LARS (30-42 points).6 Hence, it enables 
quantification of the severity of intestinal and 
defecatory dysfunction following anterior 
resection. The EORTC QLQ-30 is a validated 30-
item questionnaire designed to assess quality 
of life in cancer patients. The higher the score 
was suggestive of better quality of life and 
better functioning level.7 
Participants were asked to return the consent 
form and the questionnaire in a paid self-
addressed envelope. Patients who failed to 
answer the questionnaire were contacted by 
phone and encouraged to participate to 
increase the response rate.  
The following data on patients’ demographic 
(age, sex, comorbidities), tumour related 
factors (distance from anal verge, histological 
and MRI based TNM staging) and stoma 
related data (presence, type, time before 
closure) were collected. iSoft Clinical Manager 
(iCM) and electronic case summaries were 
used to collect clinical variables. The cancer 
staging was based on American Joint 
Commission on Cancer (AJCC) Tumor Node 
metastasis (TNM) classification system. 
Analysis was performed using IBM SPSS® 
Statistics. The relationship between possible 
risk factors and the severity of LARS as the 
dependent variable was analysed using ordinal 
logistic regression. Categorical variables were 
assessed using one-way ANOVA. Scheffe post-
hoc test was used for analysis of variance. 
Statistical significance was set at p<0.05. The 




179 patients had anterior resection between 
January 2014 and December 2016; out of 
which 124 patients failed to fit the inclusion 
criteria hence, 57 patients were eligible to 
participate.  Only 1 patient failed to return the 
questionnaire and one questionnaire was 
invalid as several answers were selected 
simultaneously. Thus the study population was 
composed of 55 patients (Figure 1). 
Table 1 shows the demographic and 
therapeutic characteristics of the studied 
participants. Most of the participants were 
male (69%, n=38) and had an overall  mean age 
of 65 years. One quarter of the patients were 
diabetic (25%, n=14), 71% (n=39) received 
neoadjuvant therapy whilst 44% (n=44) had 
adjuvant therapy as decided by the 
multidisciplinary team.  In most patients rectal 
cancer was between 5-10cm from anal verge 
(60%, n=33). Most patients had T3 disease with 
no lymph node involvement. (Table 2). Sixty-
four percent of procedures (n=35) were 
performed using an open technique, with 
laparoscopy being employed in one third of 
patients. Four percent of patients (n=2) 
required conversion to open with adhesion 
being the reasons for conversion. A 
defunctioning stoma was created in 51% of 
patients (n=28) with the majority of these 
having loop ileostomy. Stoma reversal was 
performed with a mean of 215 days after 
primary surgery.  
LARS symptoms were identified in 51% of 
patients (n=27); classified as minor in 23% of 
patients (n=13) and major in 28% of patients 
(n=15) (Figure 2). The mean time from surgery 
to patients assessment of LARS though the 
questionnaire was 995 days.
46
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Figure 1 Flow chart of patient selection 
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Frequency (n=55) Percentage (%) 
Gender 
  
Male 38 69 
Female 17 31 
Mean Age (years)  65 years 
Diabetes mellitus 
  
Yes 14 25 
No 41 75 
Hypertension 
  
Yes 29 53 
No 26 47 
Neoadjuvant therapy   
Pre-operative radiotherapy 39 71 
Pre-operative chemotherapy 26 47 
Adjuvant therapy   
Post-operative radiotherapy 0 0 
Post-operative chemotherapy 24 44 
Distance from anal verge (cm)   
<5 1 2 
5-10 33 60 
10-15 21 38 
Surgical technique   
Open 35 64 
Laparoscopic 18 33 
Conversion to open 2 4 
Presence of stoma   
Ileostomy 26 47 
Colostomy 2 4 
No stoma 27 49 
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Figure 2  Stratification of patients according to LARS symtoms 
3.1 Association 
Our logistic analysis showed a significant 
association of LARS with distance from anal 
verge (OR3.55, 95% CI 1.22-10.28; p=0.02), 
preoperative radiotherapy (OR 4.66, 95% CI 
1.44-15.15; p=0.01) and presence of stoma 
(OR3.36, 95%CI 1.21-9.30; p=0.02). No 
significant association was found between 
gender, diabetes mellitus, tumour staging, 
surgical technique and interval from stoma 
reversal (Table 2).   
3.2 Quality of life 
The larger difference in mean quality of life 
scores was between the Major LARS group and 
each of the other two groups as demonstrated 
in Figure 3. One-way ANOVA analysing quality 
of life by LARS showed that these differences 
in quality of life score are statistically 
significant.  The Scheffe post-hoc test 
ascertained that the significant difference lies 
between the No LARS and the Major LARS 
groups (p<0.0005; 95% CI 
0.81 - 1.94) and between the Minor LARS and 
the Major LARS groups (p<0.01; 95% CI 0.39 - 
1.64) (Figure 4). 
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Percentage  (%) 
Pathological stage, T 
  
T0 10  18 
T1 4  7 
T2 16  29 
T3 23  42 
T4 2  4 
Pathology, N 
  
N0 33  60 
N1 17  31 
N2 5 9  
MRI stage, T 
  
No MRI 8 15 
T0 2 4 
T1 0 0 
T2 16 29 
T3 27 49 
T4 2 4 
MRI stage, N 
  
N0 26 47 
N1 13 24 
N2 8 15 
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DISCUSSION  
In our study, more than half the patients who 
underwent anterior resection for rectal cancer 
presented with anterior resection syndrome. 
Of these, 28% of these experienced major 
symptoms even after one year post 
operatively.  Although functional bowel 
changes are more severe in the initial 12 
months postoperatively, after which 
stabilisation in symptoms is achieved, this 
study demonstrates that the symptoms 
experienced in LARS are not transient with its 
effects persisting following one year post 
operatively. This is comparable to other 
international studies.4,8-10 
Literature demonstrates multiple factors 
which may contribute to LARS. These include 
the     patient’s   age,3 gender,3,8,11 surgical 
techniques,11-12 presence of stoma,9,11,13-14 
level of anastomosis4,11,15 and radiotherapy.9,11 
Consistent with other literature, our study 
showed that  distance from anal verge 
(p=0.02), preoperative radiotherapy (p=0.01) 
and presence of stoma (p=0.02) are 
significantly associated with LARS.    Pre-
operative radiotherapy and presence of stoma 
may not have a direct causal relationship to 
LARS but may be a co-variant of the distance 
from anal verge.  Patients who have a rectal 
tumour at low distance from anal verge are 
more likely to have a protective temporary 
stoma to secure anastomosis and receive neo-
adjuvant therapy hence further contributing to 
LARS. Conversely, patients who have distal 
sited tumours  have a decrease in rectal 
capacity and reservoir following resection 
whilst radiotherapy is known to cause pelvic 
nerve damage, suggesting their independent 
aspect in contributing to LARS.    
LARS was noted to exert significant impact on 
patient’s quality of life. Our study showed that 
the perception of quality of life was 
significantly worse in patients who were 
classified to have major LARS compared to 
those who did not suffer from LARS or had 
minor LARS symptoms. This is consistent with 
the study by Juul et al. which assessed the 
effect of LARS across multiple European 
countries.16  
The strengths of the study include the use of 
validated scores for classification of LARS and 
quality of life increasing the validity of the 
results. This study had a response rate of 96% 
suggesting adequate representation of the 
population studied.  As the study was 
performed by filling in an anonymous 
questionnaire, the patients were more likely to 
express their symptoms rather than by 
patient’s interview; hence being 
representative of the true incidence of LARS 
and its impact on quality of life. Nevertheless, 
the limitations of this study include its 
retrospective study design and the small study 
population. 
This study adds to the understanding of the 
contributing factors leading to LARS, the long 
term effects of this syndrome post-operatively 
and its impact on quality of life.   Based on our 
study findings, the factors contributing to 
LARS are noted to be largely non-modifiable. 
Hence, adequate consideration should be 
given in the pre-operative counselling and 
post-operative identification of the syndrome 
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CONCLUSION 
With the improved surgical techniques, 
colorectal procedures which achieve adequate 
surgical margin and total mesorectal excision 
are  the current surgical standard for rectal 
carcinoma. However restoration of bowel 
continuity does not mean satisfactory bowel 
function. More than half the patients who had 
anterior resection suffer from LARS at least 
one year after surgery. Given its impact on 
patient’s quality of life, pre-operative 
counselling  on bowel dysfunction is crucial in 
patients who are scheduled to undergo 
anterior resection. Additionally, patients 
should be adequately evaluated during 
postoperative follow-up to enable early 
identification of the syndrome and provide a 




Facts already known: 
 In Europe, colorectal cancer is the second 
most common cancer in women and third 
most common in men. 
 Around half of all colorectal cancer cases 
affect the rectum. 
 Anterior resection is a sphincter sparing 
surgery for the treatment of rectal cancer.  
New findings: 
 The effects of low anterior resection 
syndrome (LARS) are not transient with its 
effects persisting 1 year post operatively. 
 The distance from anal verge, preoperative 
radiotherapy and presence of stoma are 
significantly associated with LARS.  
 Patients suffering from major LARS have a 
significant decrease in their quality of life
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